77 related articles for article (PubMed ID: 5869366)
1. [The clinical problem of Rh factor incompatibility in obstetrics].
Krug A
Rev Chil Obstet Ginecol; 1965; 30(2):132-41. PubMed ID: 5869366
[No Abstract] [Full Text] [Related]
2. [Isoserological Rh-factor incompatibility of mother and fetus].
Chernukha EA
Feldsher Akush; 1981; 46(10):51-5. PubMed ID: 6795064
[No Abstract] [Full Text] [Related]
3. Modern obstetric management of the Rh problem.
Douglas RG; Queenan JT
N C Med J; 1966 Nov; 27(11):521-7. PubMed ID: 5232145
[No Abstract] [Full Text] [Related]
4. [Experiences with the use of therapeutic plasmapheresis in Rh incompatibility].
Debska-Jaroszewicz D; Szczygielski A; Fułczyńska-Staniec U; Zieliński K
Wiad Lek; 1983 Sep; 36(18):1507-13. PubMed ID: 6420991
[No Abstract] [Full Text] [Related]
5. [The Kleihauer test and directed prevention of hemolytic disease of the newborn due to materno-fetal Rh-factor isoimmunization. Preventive note].
De Luca P; Adinolfi G; Corbo M
Minerva Ginecol; 1980 Dec; 32(12):1179-81. PubMed ID: 6793940
[No Abstract] [Full Text] [Related]
6. [Selective Rh prevention in pregnancy].
Helderweirt G
Verh K Acad Geneeskd Belg; 1983; 45(3):261-74. PubMed ID: 6421025
[No Abstract] [Full Text] [Related]
7. [Recent considerations on the Rh factor in obstetric practice].
Gagnon MG
Union Med Can; 1966 Dec; 95(12):1408-12. PubMed ID: 5996222
[No Abstract] [Full Text] [Related]
8. [On the problem of ABO-incompatibility as a cause of abortion].
Krieg H; Kasper K
Geburtshilfe Frauenheilkd; 1967 Jun; 27(7):679-90. PubMed ID: 5600267
[No Abstract] [Full Text] [Related]
9. Plasmapheresis in Rh immunized pregnant women.
Simonovits I; Vedrödi K; Jókuti I; Forgács J; Gy S
Acta Haematol Pol; 1981; 12(2):65-7. PubMed ID: 6795880
[No Abstract] [Full Text] [Related]
10. [Processed autologous fresh frozen plasma for Rh- sensitized pregnant woman].
Tominaga N; Tsubakio T; Hisayama J; Katagiri S; Yonezawa T
Rinsho Ketsueki; 1983 Jul; 24(7):934-8. PubMed ID: 6415319
[No Abstract] [Full Text] [Related]
11. Role of IVIG in preventing exchange transfusions in Rh hemolytic disease.
Aylin T; Berkan G
Indian Pediatr; 2005 Jan; 42(1):77-9. PubMed ID: 15695869
[No Abstract] [Full Text] [Related]
12. [Fetal monitoring during induction of labor with prostaglandin E2 in parturients with blood group incompatibility].
Otoka A; Otoka K
Wiad Lek; 1983 Feb; 36(4):299-306. PubMed ID: 6407213
[No Abstract] [Full Text] [Related]
13. [A case of materno-fetal immunization without hemolytic disease].
Guaschino R; Alesso D; Papili F
Minerva Pediatr; 1982 Jan; 34(1-2):31-2. PubMed ID: 6803119
[No Abstract] [Full Text] [Related]
14. Blood transfusion: the hidden dangers.
Anderson T
Pract Midwife; 2004 Mar; 7(3):12-6. PubMed ID: 15058056
[No Abstract] [Full Text] [Related]
15. [Gynecological immunology. 6. Blood group incompatibility in pregnancy].
Takeuchi S; Omomo Y
Josanpu Zasshi; 1987 Sep; 41(9):791-5. PubMed ID: 3682327
[No Abstract] [Full Text] [Related]
16. [High-frequency variants of quantitative immunoelectrophoresis].
Zorin NA
Lab Delo; 1983; (10):40-3. PubMed ID: 6196532
[No Abstract] [Full Text] [Related]
17. [Processed autologous fresh frozen plasma for Rho (D)-sensitized pregnant woman].
Ueda Y; Ueda R; Goya T; Maeda T; Yamada N
Rinsho Ketsueki; 1983 Jul; 24(7):929-33. PubMed ID: 6415318
[No Abstract] [Full Text] [Related]
18. Hemolytic disease of the newborn due to combination of anti-E and anti-S in the first pregnancy.
Kanra T; Tunçer M; Pirnar A
Turk J Pediatr; 1983; 25(1):49-54. PubMed ID: 6417855
[No Abstract] [Full Text] [Related]
19. [Use of citroflavonoids in the prevention of complications due to fetomaternal blood incompatibility].
Garès R
Bull Fed Soc Gynecol Obstet Lang Fr; 1966; 18(3):288-90. PubMed ID: 5962895
[No Abstract] [Full Text] [Related]
20. [The condition of newborn infants from risk pregnancies and HPL concentration in the blood of their mothers].
Rybakowa M; Miecznikowski A; Lauterbach R
Folia Med Cracov; 1984; 25(1-2):3-7. PubMed ID: 6437943
[No Abstract] [Full Text] [Related]
[Next] [New Search]
